LINC00152 promotes pancreatic cancer cell proliferation, migration and invasion via targeting miR-150

• Published in: American journal of translational research Vol. 12; no. 5; pp. 2241 - 2256
• Main Authors: Yuan, Zhi-Jun, Yu, Can, Hu, Xiao-Fang, He, Yi, Chen, Po, Ouyang, Sha-Xi
• Format: Journal Article
• Language: English
• Published: e-Century Publishing Corporation 01.01.2020
• Subjects: Original
• ISSN: 1943-8141; 1943-8141

Pancreatic cancer (PC) is one of the top deaths causing cancers with low 5-year survival rate. Long non-coding RNAs (lncRNAs) are recognized as a crucial type of nonprotein-coding transcripts implicated in tumorigenesis. Emerging evidence has implied that LINC00152 exerts the potential oncogenic functions in various cancers. Nevertheless, the role of LINC00152 in PC remains elusive. In the present study, we found that LINC00152 was significantly up-regulated while miR-150 was down-regulated both in tissues and cell lines of PC, indicating their negative correlation in PC progression. Functionally, overexpression of LINC00152 promoted cell proliferation, migration and invasion, while LINC00152 knockdown reversed these effects. Mechanistic experiments reveal that miR-150 acted as a target of LINC00152 confirmed by luciferase reporter assay. Moreover, inhibition of miR-150 could markedly attenuate the suppression of cell proliferation, migration and invasion by knocking down LINC00152. Altogether, our findings concluded that LINC00152 facilitated PC progression through inhibiting miR-150 expression, indicating an innovative therapeutic target for PC.